Naqvi Asghar, Cuchacovich Raquel, Saketkoo Lesley, Espinoza Luis R
Section of Rheumatology, Department of Internal Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Am J Med Sci. 2008 Feb;335(2):145-8. doi: 10.1097/MAJ.0b013e3180a5e957.
Charcot arthropathy is a relatively rare complication of diabetic neuropathy that may lead to significant discomfort, deformity, and disability, including severe function loss and limb amputation. Initial diagnosis of Charcot arthropathy is often delayed for several weeks, and it is compounded by the lack of specific clinical and laboratory diagnostic parameters. Increasing understanding of the underlying pathogenic events provide strong support for an important role for osteoclastic activity and pro-inflammatory cytokines. This has led to the successful use of bisphosphonates in patients with acute presentation. Herein we report 3 patients with active (acute) Charcot arthropathy secondary to diabetic neuropathy that exhibited an excellent long-term clinical response to intravenous pamidronate therapy.
夏科氏关节病是糖尿病神经病变相对罕见的并发症,可能导致严重不适、畸形和残疾,包括严重功能丧失和肢体截肢。夏科氏关节病的最初诊断往往会延迟数周,而且由于缺乏特定的临床和实验室诊断参数而变得更加复杂。对潜在致病事件的深入了解为破骨细胞活性和促炎细胞因子的重要作用提供了有力支持。这已促使双膦酸盐在急性发病患者中成功应用。在此,我们报告3例继发于糖尿病神经病变的活动期(急性)夏科氏关节病患者,他们对静脉注射帕米膦酸治疗表现出极佳的长期临床反应。